# Amgen says drug combo cuts risk of death by 58% in patients with aggressive lung cancer

- Source: CNBC
- Published: 2026-10-24T14:30:01+00:00
- Category: Markets
- Original: https://www.cnbc.com/2026/10/24/amgen-imdelltra-lung-cancer-data.html
- Canonical: https://groundlevelnews.com/story/amgen-says-drug-combo-cuts-risk-of-death-by-58-in-patients-with-aggres-835a6f/

A drug from Amgen could give patients with an aggressive form of lung cancer significantly more time to live when added to an immunotherapy from AstraZeneca.

_Ground Level News shows a short summary only; the full article and all rights belong to CNBC._